Your search returned 1013 results

Should Employers Add Fentanyl to Their Drug Test Panel?

Across the U.S., the opioid crisis has taken a deadly turn with the rapid spread of fentanyl, a synthetic opioid up to 50 times stronger than heroin and 100 times more potent than morphine. While public health agencies have sounded the alarm, many employers remain unaware of a significant gap in their drug testing protocols: fentanyl usually isn't typically included in standard drug testing panels—despite widespread assumptions to the contrary.

https://disa.com/news/should-employers-add-fentanyl-to-their-drug-test-panel

Spring Into Compliance: Trends and Best Practices for Background Screening

Background screening continues to be a critical component of organizational risk management and regulatory compliance. In the recent webinar "Spring Into Compliance: Background Screening Best Practices and Trends," Chad Ascar, Director of Compliance Integration at DISA Global Solutions, outlined key legal and procedural considerations employers need to understand in today's evolving landscape. Topics included disclosure and authorization requirements under the Fair Credit Reporting Act (FCRA), adverse action procedures, individualized assessments, negligent hiring risks, and emerging data privacy responsibilities. The session provided employers practical strategies for protecting their workplace, staying compliant, and adapting to new screening challenges.

https://disa.com/news/spring-into-compliance-trends-and-best-practices-for-background-screening

The Importance of Verifying Valid Prescriptions

In today's employment landscape, the intersection of workplace safety, drug testing, and employee rights is becoming increasingly complex. One critical piece employers must understand is what constitutes a valid prescription. Having this knowledge is essential not only for compliance with various employment laws but also for maintaining a safe and effective work environment. Failing to properly recognize or manage issues around prescription medications can expose companies to significant risks — from workplace accidents to costly litigation. Understanding what makes a prescription valid, why it matters for employers, and how to handle prescription-related situations in the workplace is essential for maintaining compliance and safety.

https://disa.com/news/the-importance-of-verifying-valid-prescriptions

Eliminating Safety Gaps Through Human Performance and Policy Alignment

In high-risk industries, workplace safety relies not only on policies and procedures but also on real-time awareness of human factors. Ensuring workplace safety begins with thorough background checks and drug testing, which verify an employee’s qualifications and compliance. Human performance monitoring strengthens this foundation by detecting real-time risks such as fatigue or cognitive decline. When used together, they help organizations protect their people and operations more effectively. This approach supports early identification of risk and enables timely interventions that can help reduce the potential for harm. When safety programs consider both the compliance and performance sides, organizations can reduce uncertainty and close dangerous gaps in coverage.

https://disa.com/news/eliminating-safety-gaps-through-human-performance-and-policy-alignment

How Executive Orders Could Reshape Direct Observation Drug Testing for Transgender Employees

Drug testing plays a pivotal role in workplace safety and compliance particularly in safety-sensitive roles where direct observation protocols are sometimes required. Current DOT guidelines allow employees to self-identify their gender to determine who observes the collection, providing flexibility for transgender and nonbinary individuals. However, the recent executive order 14168 aiming to define gender strictly as male or female based on biological sex could upend this approach. If enforced, the DOT may be required to revise its current practices—leaving employers uncertain about how to navigate compliance requirements while continuing to uphold respectful, inclusive workplace policies.

https://disa.com/news/how-executive-orders-could-reshape-direct-observation-drug-testing-for-transgender-employees

DISA Earns Reaccreditation from the Professional Background Screening Association (PBSA)

DISA Global Solutions is proud to announce a successful reaccreditation by the Professional Background Screening Association (PBSA)PBSA accreditation represents the gold standard in the background screening industry, a prestigious honor only about 10% of background screening companies nationwide achieve. PBSA accreditation is a rigorous, multi-month process that evaluates policies, procedures, legal compliance, consumer protection practices, and overall service quality. The reaccreditation process, required every five years, is a rigorous audit that validates DISA’s commitment to excellence, compliance, and protecting our clients.

https://disa.com/news/disa-reaccredited-by-pbsa